NO985068D0 - Vaksiner for behandling av lymfom og leukemi - Google Patents

Vaksiner for behandling av lymfom og leukemi

Info

Publication number
NO985068D0
NO985068D0 NO985068A NO985068A NO985068D0 NO 985068 D0 NO985068 D0 NO 985068D0 NO 985068 A NO985068 A NO 985068A NO 985068 A NO985068 A NO 985068A NO 985068 D0 NO985068 D0 NO 985068D0
Authority
NO
Norway
Prior art keywords
vaccines
lymphoma
leukemia
treatment
Prior art date
Application number
NO985068A
Other languages
English (en)
Other versions
NO985068L (no
NO325051B1 (no
Inventor
Jr Dan W Denney
Original Assignee
Genitope Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/644,664 external-priority patent/US5776746A/en
Application filed by Genitope Corp filed Critical Genitope Corp
Publication of NO985068D0 publication Critical patent/NO985068D0/no
Publication of NO985068L publication Critical patent/NO985068L/no
Publication of NO325051B1 publication Critical patent/NO325051B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
    • C12N9/003—Dihydrofolate reductase [DHFR] (1.5.1.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
NO19985068A 1996-05-01 1998-10-30 Multivalent vaksine for et individ som har B-cellelymfom samt fremgangsmate NO325051B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/644,664 US5776746A (en) 1996-05-01 1996-05-01 Gene amplification methods
US08/761,277 US5972334A (en) 1996-05-01 1996-12-06 Vaccines for treatment of lymphoma and leukemia
PCT/US1997/007039 WO1997041244A1 (en) 1996-05-01 1997-04-25 Vaccines for treatment of lymphoma and leukemia

Publications (3)

Publication Number Publication Date
NO985068D0 true NO985068D0 (no) 1998-10-30
NO985068L NO985068L (no) 1998-12-28
NO325051B1 NO325051B1 (no) 2008-01-21

Family

ID=27094524

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985068A NO325051B1 (no) 1996-05-01 1998-10-30 Multivalent vaksine for et individ som har B-cellelymfom samt fremgangsmate

Country Status (8)

Country Link
EP (1) EP0910655B1 (no)
JP (4) JP2002509426A (no)
AU (1) AU716257B2 (no)
CA (1) CA2248653C (no)
IL (1) IL126121A0 (no)
NO (1) NO325051B1 (no)
TW (1) TWI263504B (no)
WO (1) WO1997041244A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0896622A4 (en) 1996-03-19 2004-11-03 Human Genome Sciences Inc CHEMOKINE ALPHA 2
EP0953639A1 (en) * 1998-04-30 1999-11-03 Boehringer Ingelheim International GmbH FAPalpha-specific antibody with improved producibility
US6455677B1 (en) 1998-04-30 2002-09-24 Boehringer Ingelheim International Gmbh FAPα-specific antibody with improved producibility
US20030022257A1 (en) * 2000-07-21 2003-01-30 Macina Roberto A. Compositions and methods relating to lung specific genes
MXPA03001141A (es) * 2000-08-11 2004-10-04 Favrille Inc Metodo y composicion para alterar una patologia mediada por celulas b.
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices
EP0433900B1 (en) * 1989-12-13 1995-09-20 Yeda Research And Development Company Limited Expression of the recombinant tumor necrosis factor binding protein I (TBP-I)
US6099846A (en) * 1992-10-14 2000-08-08 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of B cell lymphoma and tumor resistance using idiotype/cytokine conjugates

Also Published As

Publication number Publication date
EP0910655B1 (en) 2010-02-10
EP0910655A4 (en) 2006-05-03
IL126121A0 (en) 1999-05-09
CA2248653C (en) 2003-08-12
CA2248653A1 (en) 1997-11-06
JP2002509426A (ja) 2002-03-26
NO985068L (no) 1998-12-28
JP2007277266A (ja) 2007-10-25
AU716257B2 (en) 2000-02-24
WO1997041244A1 (en) 1997-11-06
JP2007252385A (ja) 2007-10-04
JP2004035562A (ja) 2004-02-05
EP0910655A1 (en) 1999-04-28
TWI263504B (en) 2006-10-11
NO325051B1 (no) 2008-01-21
AU2814597A (en) 1997-11-19

Similar Documents

Publication Publication Date Title
ZA973701B (en) Vaccines for treatment of lymphoma and leukemia.
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
NO971015L (no) Forbindelser og metoder for behandling av cancer
NO983266D0 (no) Distribuert Behandling
DE69704612D1 (de) Dentalmasse und dental-produkt
DE69719108D1 (de) Plasmabehandlungsgerät
DE69718990T2 (de) Behandlungsgerät
NO953991D0 (no) Ultrasomisk og elektro-kirurgisk håndstykke av piezotype
DE69331967T2 (de) Gefässstent und zugehörige einführungsvorrichtung
DE69216277D1 (de) Evakuierungssystem und -verfahren
NO991701D0 (no) HIV og cancer behandling
DE69515626T2 (de) Plasmabehandlungsverfahren und -vorrichtung
NO983512D0 (no) Midler for behandling og forhindring av AIDS
NO964541L (no) Porphacyanin og CNC-utvidete porphyriner
NO983263L (no) Distribuert behandling
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO985068L (no) Vaksiner for behandling av lymfom og leukemi
DE69709876D1 (de) Kieferorthopädische und parodontologische vorrichtungen
DE69526175D1 (de) Behandlungsgerät
DE69727094D1 (de) Plasmabehandlungsvorrichtung und Schutzteil dafür
DE69528458D1 (de) Bandbehandlungsvorrichtung
DE69516439D1 (de) Behandlungsgerät
ATA218894A (de) Physikotherapeutische behandlungsvorrichtung
DE29517429U1 (de) Toilettentisch und Toilettentisch-Kombination
KR940002718U (ko) 치질예방 및 치료기

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees